LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)
$20.39 1.12 (5.8121%)
Analysed LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) News Sources
Legend Biotech (LEGN) Stock May Be Undervalued Despite A 70% 3 Year Fall
01-09-2026
yahoo.com
Legend Biotech (LEGN) Heads To Morgan Stanley Conference, Is The 57% Valuation Gap Justified?
02-09-2026
yahoo.com
Legend Naming Novartis Executive as CEO
15-09-2026
wsj.com
Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer
15-09-2026
yahoo.com
LEGN’s New CEO From Novartis Paves Way For Buyout Speculation
15-09-2026
stocktwits.com
Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion
25-09-2026
yahoo.com
Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma
01-10-2026
yahoo.com
Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says
02-10-2026
yahoo.com
Legend Biotech (LEGN) Tests Its Valuation After Fresh CARVYKTI Five Year Data
04-10-2026
yahoo.com
Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy
15-10-2026
yahoo.com
What is the current price of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)?
The current price of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) is $20.39.
LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) since the previous trading day is $1.12.
LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) since the previous trading day is 5.8121%.
What is the most recent average sentiment score for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)?
The most recent average sentiment score for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)?
The most recent sentiment for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) is .
SEC-8K** Filing Available For LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.